mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.005 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.005 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.18 |
0.006 |